Victor Weigman, Ph.D. | April 24, 2017

Data Science Challenges for Cancer Immunotherapy

South Big Data Hub Presentation, April 2017
New cancer immunotherapies are providing fresh hope to patients who previously had few treatment options. However, immuno-oncology exists at the intersection of oncology, immunology, and molecular biology, each of which bring significant data challenges. 

Download Victor Weigman's presentation from the South Big Data Hub Data Science Roundtable to hear him discuss data science challenges for cancer immunotherapy clinical trials and the evolution of “big data” in immuno-oncology.

Victor Weigman, Ph.D., Director, Translational Genomics

Related Services:
Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach

New Opportunities for Immuno-oncology Clinical Development Programs through T cell/B cell Repertoire Profiling

Immune repertoire profiling provides better outcomes for immuno-oncology development programs

The Power of the Central Laboratory for Immuno-Oncology Drug Development

Read More